Navigation Links
Valeant Pharmaceuticals Announces Mailing of Offer and Take-Over Bid Circular to Shareholders of Afexa
Date:9/9/2011

the take-over bid circular mailed today to Afexa's shareholders. The take-over bid circular and related documents and the Directors' Circular will be filed today on SEDAR and will be available at www.sedar.com. The Offer is subject to a number of customary conditions, including there being deposited under the Offer and not withdrawn at the expiration of the Offer such number of Common Shares that represent at least 66 2/3% of the outstanding Common Shares calculated on a fully-diluted basis, there being no material adverse changes to Afexa's business and the receipt of all necessary regulatory approvals.

Afexa has retained Georgeson Shareholder Communications Canada Inc. as information agent. Computershare Investor Services Inc. is the depositary for the Offer. Any questions or requests for assistance or further information on how to tender Common Shares to the Offer may be directed to, and copies of the above referenced documents may be obtained by contacting, the information agent at 1-866-676-3005 or by email at askus@georgeson.com or by contacting the depositary at 1-800-564-6253, or by email at corporateactions@computershare.com. Shareholders whose Common Shares are registered in the name of a broker, investment dealer, bank, trust company or other nominee should contact such nominee for assistance in depositing their Common Shares to the Offer.

About Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals International, Inc. is a multi-national specialty pharmaceutical company that develops, manufacturers and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. More information about Valeant Pharmaceuticals International, Inc. can be found at www.valeant.com.

Fo
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Valeant to Acquire Polish Products
2. GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
3. Valeant and Biovail Announce Results of Special Meetings of Shareholders
4. Valeant Pharmaceuticals Announces Redemption and Defeasance of 7.625% Senior Notes Due 2020 and 8.375% Senior Notes Due 2016
5. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
6. Valeant Pharmaceuticals Reports 2010 Third Quarter Financial Results
7. Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan
8. Valeant Announces Pricing of Senior Notes
9. Valeant Pharmaceuticals Announces Appointment of Robert A. Ingram and Resignation of William M. Wells as Chairman
10. Valeant Pharmaceuticals Appoints Philip W. Loberg as Interim CFO
11. Regulatory Update - GSK and Valeant Receive Positive Opinion in Europe From the CHMP for Trobalt (Retigabine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 2015 Bionomics Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical ... therapeutics for the treatment of cancer and diseases of ... data from three of its most advanced oncology programs ... 106 th Annual Meeting being held from April ... USA. The presentation on the BNC105 ...
(Date:4/16/2015)... April 16, 2015 Vanda Pharmaceuticals Inc. (Vanda) ... the development and commercialization of products for the treatment ... release results for the first quarter of 2015 on ... The Company will host a conference call ... during which Vanda management will discuss the first quarter ...
(Date:4/16/2015)... 16, 2015 A drug commonly taken to prevent ... with multiple sclerosis (MS), according to a study released today ... 67th Annual Meeting in Washington, DC , ... of people with MS experience at some point in their ... nerve carrying vision from the eye to the brain gets ...
Breaking Medicine Technology:Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 2Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 3Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 4Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 5Vanda Pharmaceuticals to Announce First Quarter 2015 Financial Results on May 6, 2015 2Epilepsy Drug May Preserve Eyesight for People with MS 2
... Calif., Nov. 5 Bionovo, Inc. (Nasdaq: BNVI ... the unmet needs in women,s health and oncology, today ... three months ended September 30, 2009. , Subsequent to ... successfully completed a public offering and issued approximately 31 ...
... , SAN DIEGO, Nov. 5, 2009 Amylin Pharmaceuticals, Inc. ... Annual Credit Suisse Healthcare Conference in Phoenix, Arizona on Wednesday, ... ET. Mark Foletta, senior vice president of finance and ... corporate overview. , The audio portion of the presentation will ...
Cached Medicine Technology:Bionovo Announces Third Quarter 2009 Highlights and Financial Results 2Bionovo Announces Third Quarter 2009 Highlights and Financial Results 3Bionovo Announces Third Quarter 2009 Highlights and Financial Results 4Bionovo Announces Third Quarter 2009 Highlights and Financial Results 5Bionovo Announces Third Quarter 2009 Highlights and Financial Results 6Bionovo Announces Third Quarter 2009 Highlights and Financial Results 7Bionovo Announces Third Quarter 2009 Highlights and Financial Results 8Bionovo Announces Third Quarter 2009 Highlights and Financial Results 9
(Date:4/18/2015)... 18, 2015 Carinsurancequotesinfo.com has released a ... cover physical injuries caused by a car accident. ... coverage for a vehicle. A policy can pay for ... accident. Drivers should always carry appropriate coverage when they ... can be bought with several important riders that offer ...
(Date:4/18/2015)... "I wanted to live a ... healthful juice that contained essential vitamins, minerals and ... increases my energy, improves skin elasticity and gives ... Tapp's Juice to contain fruits, vegetables and other ... and mental fatigue. It features a great taste. ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 Lower-auto-insurance.com has ... accurate auto insurance quotes . , ... policies by comparing quotes. A professional insurance brokerage website ... insurance quotes, in a simple, convenient way. The whole ... to anyone. , Comparing online car insurance quotes ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 More than ... sale now at TheCelebrityDresses.com, the #1 online store carrying ... ongoing many girls have got their perfect dresses for ... the celebrity fashion prom dresses at TheCelebrityDresses.com would be ... designed more than 2000 prom dresses inspired by the ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 PHOENIX, ARIZONA ... County, along with 11 other secure destruction professionals across ... Destruction Specialists (CSDS). He will now display “CSDS” as ... were offered before the National Association of Information Destruction ... and another Grapevine, Texas. Of the 20 people who ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Plans Can Cover Physical Injuries Caused By An Accident! 2Health News:Auto Insurance Quotes Can Provide Accurate Results! 2Health News:Prom Dresses 2015 on Sale at TheCelebrityDresses.com 2
... Calif., May 7 The CPF today announced that the ... would authorize $16 million in new federal funding for pulmonary ... 27 Members of the U.S. House of Representatives. The ... and awareness of pulmonary fibrosis, a terminal lung disease with ...
... HMSY ) today announced that it will present ... Conference, which will be held Tuesday, May 12 ... City. The Company will present on Tuesday, May 12th at ... be accessed through our website at http://www.hms.com/investor_relations/investors_presentations.asp ...
... Conseco, Inc. (NYSE: CNO ) today responded ... subscribers who hold Conseco, Inc. stock vote for eight ... dissident nominee for the ninth director up for election."RMG ... to elect a dissident at Conseco,s upcoming annual meeting ...
... Facial Surgery in a Live Case Study for TWTRCON ... TWTRCON SF 09, the first conference focused on ... Operation Smile would be launching a groundbreaking new fundraising ... creating a live case study in which TWTRCON attendees ...
... May 7 /PRNewswire/ - Axela Inc., is pleased to ... dotLab(R) System that provides technical controls to support compliance ... will be of particular interest to those working in ... secure database, audit trails, electronic signature controls and user ...
... the U.S. once again a resounding successNEW YORK, May ... friends and supporters, joined the more than 10,000 people ... April 25th to celebrate the 15th Parkinson,s Unity Walk ... Parkinson,s disease research.This year marked an incredible year for ...
Cached Medicine News:Health News:Co-Sponsorship of Pulmonary Fibrosis Research Enhancement Act 2009 Increases to 27 Members 2Health News:Co-Sponsorship of Pulmonary Fibrosis Research Enhancement Act 2009 Increases to 27 Members 3Health News:Co-Sponsorship of Pulmonary Fibrosis Research Enhancement Act 2009 Increases to 27 Members 4Health News:Operation Smile To Launch Groundbreaking 140 Smiles Fundraising Campaign at TWTRCON SF 09 2Health News:Operation Smile To Launch Groundbreaking 140 Smiles Fundraising Campaign at TWTRCON SF 09 3Health News:Axela introduces software to support 21 CFR Part 11 Compliance for Regulated Environments 2Health News:15th Parkinson's Unity Walk A Step in the Right Direction for Parkinson's Community 2Health News:15th Parkinson's Unity Walk A Step in the Right Direction for Parkinson's Community 3
P-Series Cystourethroscope Short Bridge, examining...
Short single-horn bridge for insertion of instruments...
Albarran double-horn bridge for use with sheaths from 20-25 Fr and designed for accurate articulation of flexible devices....
Designed for accurate articulation of flexible devices....
Medicine Products: